congenital heart defects in adults. definition,etiology, classification, clinical features, diagnosis, treatment, differential diagnosis

Reading File

Finding Sources

Searching PubMed

"congenital heart disease" AND adults

Reading File

Finding Sources

Reading File

Finding Sources

Reading File

Finding Sources

I now have very comprehensive data from multiple authoritative textbooks. Let me compile the full answer.

Congenital Heart Defects in Adults (ACHD)

1. Definition

Congenital heart disease (CHD) in adults - termed Adult Congenital Heart Disease (ACHD) - refers to structural cardiovascular anomalies that were present at birth and persist, with or without prior surgical or catheter-based intervention, into adulthood (conventionally age ≥18 years). The convergence of advances in pediatric medicine, cardiology, and cardiovascular surgery has resulted in a rapidly growing population of adults with CHD. Currently, an estimated 2.4 million people are living with CHD in the United States, and two thirds of these are adults. Adults with CHD now outnumber children with CHD.

Patients are "repaired, not cured" - the majority require lifelong surveillance and many develop late complications regardless of prior surgical correction.

Goldman-Cecil Medicine, p. 604

2. Etiology

2a. Epidemiology

CHD is diagnosed in approximately 1% of births in the United States
Overall prevalence of 3-4 per 1000 adults has been documented
Nearly 300,000 Americans are estimated to have severe CHD (defined as ≥2 abnormalities, typically associated with cyanosis at birth)
The most common lesion in adults is bicuspid aortic valve (~2% of the general population), accounting for up to half of surgical aortic stenosis cases in adults
ASDs constitute 30-40% of CHD in adults; solitary VSD represents 15-20% of all congenital lesions but has high spontaneous closure rates, explaining lower adult prevalence
PDA accounts for 5-10% of congenital cardiac lesions; pulmonary stenosis and coarctation each represent 3-10%
Tetralogy of Fallot is the most common cyanotic congenital anomaly in adults

2b. Genetic & Chromosomal Determinants

About 20% of CHD is associated with a syndrome or chromosomal anomaly:

Syndrome	Gene(s)	Cardiac Defect(s)	Frequency of CHD
Down syndrome (Trisomy 21)	-	Endocardial cushion defects, VSD	~50%
Trisomy 13 & 18	-	VSD	90%
Turner syndrome (45,X)	-	Coarctation of aorta, aortic stenosis, ASD	Common
DiGeorge / 22q11.2 deletion (CATCH-22)	TBX1	Conotruncal defects, VSD, IAA	74-85%
Noonan syndrome	PTPN11, SOS1, RAF1	Dysplastic pulmonary valve stenosis, ASD, HCM	75%
Holt-Oram	TBX5	VSD, ASD, conduction defects	50%
Williams-Beuren (7q11.23 del)	ELN	Supravalvar aortic stenosis, pulmonic stenosis	80%
CHARGE	CHD7	TOF, PDA, AVSD	75-85%
Kabuki	KMT2D	CoA, BAV, VSD, TOF	50%

Braunwald's Heart Disease, p. 865

About 15% of patients with Tetralogy of Fallot have a 22q11 deletion (higher in those with a right aortic arch). Environmental and multifactorial factors account for the majority of CHD not associated with identified genetic syndromes.

3. Classification

The 2018 ACC/AHA Guidelines for the Management of Adults With Congenital Heart Disease introduced a dual classification system incorporating both anatomic complexity and physiologic stage.

3a. Anatomic Classification (ACC/AHA 2018)

Class I - Simple	Class II - Moderate Complexity	Class III - Great Complexity
Small isolated ASD	Aorto-LV fistula	Cyanotic CHD (all forms)
Small isolated VSD	Anomalous pulmonary venous drainage (partial or total)	Double-outlet ventricle
Mild isolated pulmonic stenosis	AVSD (partial or complete)	Eisenmenger syndrome
Repaired secundum ASD (no residual)	Congenital aortic/mitral valve disease	Fontan circulation
Repaired VSD (no residual)	Coarctation of the aorta	Mitral atresia
Ligated/occluded PDA	Ebstein anomaly	Single ventricle
	Moderate/large unrepaired ASD or PDA	d-TGA (all forms)
	Pulmonary valve regurgitation (mod or greater)	l-TGA (congenitally corrected TGA)
	Repaired Tetralogy of Fallot	Pulmonary atresia
	Sinus venous defect	Truncus arteriosus
	Subvalvar/supravalvar aortic stenosis	Hypoplastic left heart syndrome
	VSD with associated abnormality

3b. Physiologic Stage Classification (ACC/AHA 2018)

Stage	NYHA Class	Hemodynamics/Findings
A	I	No hemodynamic sequelae, no symptoms, no arrhythmia, normal exercise capacity
B	I-II	Mild hemodynamic sequelae; mild symptoms; no intervention needed
C	II-III	Significant hemodynamic sequelae; moderate/severe symptoms; intervention needed
D	III-IV	Severe, refractory symptoms; end-organ damage; refractory arrhythmia; severely reduced exercise tolerance

Braunwald's Heart Disease, p. 864-866

3c. Classification by Shunt Direction / Physiology

A classic physiological classification divides lesions by shunt direction:

Left-to-right shunts (acyanotic): ASD, VSD, PDA, AVSD - cause volume overload, pulmonary hypertension, Eisenmenger syndrome with reversal
Right-to-left shunts (cyanotic): Tetralogy of Fallot, Transposition of the great arteries, Tricuspid atresia, Pulmonary atresia, Truncus arteriosus
Obstructive lesions (no shunt): Pulmonary stenosis, Aortic stenosis, Coarctation of the aorta

4. Clinical Features

Clinical presentation in adults varies dramatically by lesion type, presence/absence of prior repair, and physiological stage. Key presentations:

4a. Common Symptoms Across Lesions

Dyspnea on exertion / exercise intolerance (most common presenting symptom)
Palpitations (from atrial or ventricular arrhythmias, which are extremely common in ACHD)
Cyanosis and clubbing (in right-to-left shunts and Eisenmenger syndrome)
Syncope or presyncope (arrhythmia, outflow obstruction, pulmonary hypertension)
Heart failure symptoms: edema, orthopnea, PND
Stroke or TIA: paradoxical embolism through unrepaired septal defects, thrombotic events in cyanotic heart disease
Infective endocarditis

4b. Specific Lesion Profiles

Atrial Septal Defect (ASD)

Often asymptomatic for decades; typically presents in 3rd-4th decade
Exertional dyspnea, atrial arrhythmias (AFib/flutter), paradoxical embolism
Signs: wide fixed split S2, pulmonary flow murmur (ejection systolic at upper left sternal border), right ventricular heave
Unrepaired large ASDs lead to Eisenmenger syndrome over decades

Ventricular Septal Defect (VSD)

Small: often asymptomatic (maladie de Roger); harsh holosystolic murmur at left sternal border
Large: heart failure, pulmonary hypertension, Eisenmenger syndrome
Risk of aortic regurgitation (subarterial VSDs)

Patent Ductus Arteriosus (PDA)

Small: continuous "machinery" murmur, subclavicular
Large: wide pulse pressure, bounding pulses, differential cyanosis (lower body cyanosis with Eisenmenger PDA), heart failure

Pulmonary Stenosis

Often well tolerated even into adulthood if mild/moderate
Exertional dyspnea, right heart failure in severe cases
Ejection systolic murmur at upper left sternal border with ejection click; widely split S2

Tetralogy of Fallot (post-repair)

Most common cyanotic lesion in adults
Late complications after repair include: pulmonary regurgitation (leading cause of RV dilatation and failure), sustained ventricular tachycardia, sudden cardiac death, right ventricular outflow tract (RVOT) aneurysm, complete heart block
RV volume overload, exercise intolerance, right heart failure
ECG typically shows RBBB after repair

Coarctation of the Aorta

Upper extremity hypertension with lower extremity hypotension/pulse delay
Headache, nosebleeds, claudication of the legs
Associated bicuspid aortic valve (~50-85%), aortic root/ascending aortic dilatation, intracranial aneurysms
Brachial-femoral pulse delay; continuous murmur over the back; prominent collateral vessels (rib notching on CXR)

Bicuspid Aortic Valve (BAV)

Most common ACHD lesion
Aortic stenosis (calcific degeneration), aortic regurgitation, aortic root dilatation, aortic dissection
Ejection click, systolic murmur; may progress to severe AS in 5th-7th decade

Ebstein Anomaly

Apical displacement of tricuspid valve into right ventricle
Tricuspid regurgitation, right heart dilation, arrhythmias (Wolff-Parkinson-White in ~25%), paradoxical embolism through ASD/PFO
Holosystolic murmur at left lower sternal border; "sail sound" (loud widely split S1)

Eisenmenger Syndrome

End-stage consequence of large unrepaired left-to-right shunts with irreversible pulmonary hypertension and reversal to right-to-left shunting
Cyanosis, clubbing, polycythemia, hyperviscosity symptoms, hemoptysis, brain abscess, paradoxical embolism
Significantly reduced life expectancy; prognosis worse with VSD origin than ASD origin

5. Diagnosis

5a. History and Physical Examination

Thorough cardiovascular history, family history of CHD or genetic syndromes
Auscultation for murmurs, split heart sounds, clicks, and added sounds
Blood pressure in all four limbs (coarctation screening)
Assessment for cyanosis, clubbing, signs of heart failure

5b. Electrocardiography (ECG)

Atrial enlargement patterns, ventricular hypertrophy
ASD: right axis deviation, rSr' pattern (ostium secundum); left axis deviation (primum ASD/AVSD)
Post-repair TOF: RBBB (marker of RV pressure/volume overload)
Ebstein: giant P waves, delta waves (WPW), tall broad P waves ("Himalayan P waves"), prolonged PR
Coarctation: LVH

5c. Chest X-Ray (CXR)

Cardiomegaly, chamber-specific enlargement
Coarctation: rib notching (3rd-8th ribs), "figure-3" sign, aortic knuckle
ASD: right heart enlargement, pulmonary plethora
Pulmonary vascular markings: increased (left-to-right shunt), decreased (TOF), or pruned (Eisenmenger)

5d. Echocardiography (primary imaging modality)

Transthoracic echo (TTE): chamber sizes, function, valve morphology, pressure gradients, shunt direction
Transesophageal echo (TEE): better for sinus venosus ASD, pulmonary venous anatomy, intracardiac thrombus
Bubble contrast echo: patent foramen ovale and ASD detection
3D echocardiography for complex anatomy

5e. Cardiac MRI (CMR) - increasingly critical in ACHD

Gold standard for right ventricular volumes and function (important in TOF follow-up)
Quantification of pulmonary regurgitation, systemic-to-pulmonary shunt ratio (Qp:Qs)
Aortic morphology in coarctation, BAV
Anatomical delineation in complex CHD

5f. Cardiac CT Angiography (CCTA)

Coronary anatomy before reoperations
Aortic coarctation and branch vessel anatomy
Rapid imaging when CMR is not available

5g. Cardiac Catheterization

Hemodynamic assessment: pulmonary artery pressures, pulmonary vascular resistance (PVR), vasoreactivity testing (operability in Eisenmenger)
Qp:Qs ratio measurement
Coronary angiography before surgery
Interventional: device closure of ASD/VSD/PDA, balloon/stent for coarctation, balloon valvuloplasty for pulmonary stenosis

5h. Laboratory Studies

Complete blood count: polycythemia (cyanotic CHD), thrombocytopenia
Coagulation studies, iron studies (iron deficiency in Eisenmenger)
BNP/NT-proBNP: heart failure monitoring
Renal and hepatic function (Fontan-associated liver disease, renal dysfunction)
Oxygen saturation (resting and exertional)

5i. Exercise Testing

Objective functional assessment (6-minute walk test, cardiopulmonary exercise test)
Risk stratification (VO2 max, oxygen desaturation with exercise)

6. Treatment

6a. General Principles

All adults with CHD beyond simple lesions should be managed in specialist ACHD centers (ACC/AHA 2018 recommendation; evidence confirms lower mortality at dedicated centers)
Transition from pediatric to ACHD care should begin at age 12 and be completed by age 18-21

6b. Catheter-Based Interventions

ASD device closure: Percutaneous closure (Amplatzer or similar occluder) for secundum ASDs; surgery for primum ASD, sinus venosus defect, or those with associated anomalies
PDA closure: Transcatheter coil/device closure for most patients
Pulmonary balloon valvuloplasty: First-line for isolated valvar pulmonary stenosis
Coarctation stenting: Preferred in adults over surgical repair for isolated native or re-coarctation
RVOT/pulmonary valve transcatheter replacement (Melody, SAPIEN): for patients with dysfunctional RVOT conduits (e.g., post-TOF repair)

6c. Surgical Treatment

Pulmonary valve replacement (PVR): For post-TOF patients with severe pulmonary regurgitation and RV dilation (RV end-diastolic volume index >160 mL/m² or RVEF <45%)
Aortic valve surgery: BAV-related aortic stenosis or regurgitation; often combined with aortic root surgery when root ≥5.0-5.5 cm
Surgical ASD/VSD closure: When anatomy precludes catheter-based approach
MAZE procedure: For concurrent atrial arrhythmia management during cardiac surgery
Fontan revision/conversion: For failing Fontan circulation

6d. Medical Management

Heart Failure:

Standard guideline-directed medical therapy (GDMT) - ACEi/ARB, beta-blockers, MRA - is effective for ACHD with systemic LV systolic dysfunction after hemodynamic lesions are addressed
For systemic RV (l-TGA, d-TGA post-atrial switch): RAAS blockade is used, but the largest RCT did NOT show improvement in RV ejection fraction; beta-blockers also lack evidence
Pulmonary vasodilators (PDE5-inhibitors, endothelin receptor antagonists, prostacyclins) - shown to improve functional class and exercise capacity in Fontan patients and Eisenmenger syndrome
Newer agents (sacubitril/valsartan, ivabradine, dapagliflozin) have not been prospectively studied in CHD

Pulmonary Arterial Hypertension (Eisenmenger):

Pulmonary arterial hypertension-targeted therapy (bosentan, sildenafil, treprostinil, macitentan)
Phlebotomy only for symptoms of hyperviscosity (hematocrit >65%, symptoms); iron supplementation if iron deficient
Avoid systemic vasodilators, dehydration, and pregnancy

Arrhythmias:

Atrial arrhythmias (AFib/flutter) are the most common morbidity in ACHD - anticoagulation, rate/rhythm control, catheter ablation
VT and sudden cardiac death risk - ICD implantation in selected high-risk patients (prior TOF repair with RV dysfunction, inducible VT)
CRT for systemic LV with LBBB and heart failure; less established for systemic RV

Endocarditis Prophylaxis:

Recommended for: unrepaired cyanotic CHD, prosthetic valves/material, repaired CHD within 6 months, repaired CHD with residual defects adjacent to prosthetic material
Not recommended for most repaired lesions without residual defects

6e. Transplantation

Cardiac transplantation for CHD and refractory heart failure: ACHD patients account for >4% of adult heart transplants in the US
Challenges: prior sternotomies, alloimmunization, complex anatomy, multiple comorbidities (hepatic, renal, pulmonary)
UNOS Status 4 listing; higher pre-transplant mortality than acquired heart disease
Should be managed at dedicated ACHD transplant centers

6f. Exercise Recommendations

Generally encouraged in ACHD patients; restricted exercise for specific high-risk conditions (severe unrepaired coarctation, Marfan-like aortopathy, severe pulmonary hypertension, severe RVOT obstruction)
Cardiopulmonary exercise testing guides recommendations

7. Differential Diagnosis

In adults presenting with cardiac symptoms where ACHD is suspected, the following conditions enter the differential:

Presentation	ACHD Diagnoses to Consider	Key Differentiators
Exertional dyspnea + pulmonary hypertension	Eisenmenger syndrome, unrepaired ASD/VSD/PDA	Echocardiography, cardiac catheterization
Right heart failure	Ebstein anomaly, post-TOF, systemic RV	Echo: tricuspid valve morphology, RV morphology
Systemic hypertension in young adult	Coarctation of the aorta	Arm-leg BP gradient, CXR rib notching, CT aorta
Murmur found incidentally	BAV, VSD, PDA, ASD	Echo characterization
Recurrent stroke/TIA in young adult	PFO, ASD with paradoxical embolism	Bubble-contrast echo, TEE
Atrial arrhythmia in young adult	Large ASD, corrected TGA, Ebstein	ECG, echo
Cyanosis + clubbing	Eisenmenger, unrepaired TOF, pulmonary AVM	Echo with bubble contrast, cardiac MRI
Aortic stenosis in patient <60 years	Bicuspid aortic valve	Echo: valve morphology (bicuspid vs. tricuspid)
Aortic regurgitation + aortic dilatation	BAV aortopathy, Marfan syndrome	Echocardiography, genetics
Hemoptysis + pulmonary hypertension	Eisenmenger vs. primary PAH	Echo, catheterization (shunt detection)

Important acquired conditions to distinguish from ACHD:

Primary pulmonary arterial hypertension (idiopathic PAH) - no intracardiac shunt; catheterization mandatory to distinguish from Eisenmenger
Marfan syndrome with aortic root dilatation - may mimic BAV aortopathy; genetic testing, FBN1 mutation
Hypertrophic cardiomyopathy (HCM) - distinct from congenital subaortic stenosis
Rheumatic heart disease - acquired mitral/aortic valve disease; history of rheumatic fever; morphology distinct on echo
Acquired pulmonary valve disease vs. congenital pulmonary stenosis
Dilated cardiomyopathy vs. unrecognized ACHD with chronic volume/pressure overload

Key References

Braunwald's Heart Disease (10th ed.), Chapter 82: Adults with Congenital Heart Disease - classification tables adapted from 2018 AHA/ACC ACHD Guidelines (Stout KK et al., J Am Coll Cardiol 2019;73:1494-1563)
Goldman-Cecil Medicine, Chapter on Congenital Heart Disease in Adults, p. 604-605
ESC 2020 Guidelines for the Management of Adult Congenital Heart Disease

Recent Literature Update (2024-2026):

A systematic review (PMID 39609780) confirms elevated stroke risk across all CHD subtypes in adults, reinforcing the need for anticoagulation and paradoxical embolism surveillance.
A meta-analysis (PMID 39490408) on vascular health in CHD highlights premature vascular aging as an important comorbidity in ACHD patients (2025).

This is a shared conversation. Sign in to Orris to start your own chat.